BitMine Immersion Technologies is close to reaching its self-imposed cap of owning 5% of Ethereum's total supply, with only about 100,000 ETH left to buy. Once BitMine stops buying, the market will lose its largest single source of ETH demand at a time when other buyers like ETFs are pulling back and staking is releasing more ETH into circulation. This shift has already contributed to a recent price decline for Ethereum, which is down nearly 49% from its peak in August 2025. The future price recovery depends heavily on whether ETF inflows return to support demand after BitMine exits the market.
BitMine's nearing its 5% Ethereum purchase limit as context for readers. For those tracking Pluang's market as of Oct 10, 2026 03:41 WIB: out of 150 US stocks, 101 rose and 49 fell. Notably, Snowflake Inc (SNOW) gained 7.40% with 90% sell order activity, HP Inc (HPQ) dropped 6.91% but saw 73% buy orders, and Snap Inc (SNAP) rose 6.39% despite 100% sell orders. Typical hold times range from 54 to 69 days among these movers.
MannKind presented new clinical data at HFSA 2026 showing that Furoscix ReadyFlow, an autoinjector delivering subcutaneous furosemide, provides diuretic effects comparable to IV administration for treating edema in heart failure and chronic kidney di...
A securities class action lawsuit was filed against Millrose Properties, Inc. for allegedly misleading investors by not disclosing that it would lease $200 million worth of properties purchased from Lennar at a loss. The lawsuit claims Millrose misre...
Brookfield Infrastructure Corporation has postponed its special shareholder meeting to October 29, 2026, to allow more time for votes on its proposed corporate simplification. The plan aims to merge Brookfield Infrastructure Partners LP and Brookfiel...
Brookfield Renewable Partners has postponed its special unitholders' meeting to October 29, 2026, to finalize approval for its proposed corporate simplification. Over 99.7% of votes so far favor the plan, which aims to merge Brookfield Renewable Part...
MindWave Innovations Inc., a subsidiary of Apimeds Pharmaceuticals US, signed three agreements within 10 days to create dedicated blockchain networks for clients in climate finance, sports media, and insurance. Each network runs on MindWave's MindCha...
